impact factor, citescore
logo
 

LER & CER: letter to Editor Rheumatology

 

Is sirolimus a treatment option for patients with systemic lupus erythematosus?


1, 2

 

  1. Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey. nihalesatoglu@gmail.com
  2. Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey.

CER11417
2019 Vol.37, N°6 ,Suppl.122
PI 0013
LER & CER: letter to Editor Rheumatology

Free to view
(click on article PDF icon to read the article)

PMID: 31376256 [PubMed]

Received: 23/05/2018
Accepted : 17/10/2018
In Press: 12/07/2019
Published: 12/12/2019

Rheumatology Article